Cargando…

Metabolic Effects of Cortisone Acetate vs Hydrocortisone in Patients With Secondary Adrenal Insufficiency

CONTEXT: Pharmacokinetic properties of cortisone acetate (CA) and hydrocortisone (HC) differ because CA needs to be converted into cortisol to become active. OBJECTIVE: This work analyzed the metabolic consequences of switching CA to an equivalent daily dose of HC in patients with secondary adrenal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ekstrand, Elise, Esposito, Daniela, Ragnarsson, Oskar, Isgaard, Jörgen, Johannsson, Gudmundur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671249/ https://www.ncbi.nlm.nih.gov/pubmed/33241171 http://dx.doi.org/10.1210/jendso/bvaa160

Ejemplares similares

Effects of the therapy shift from cortisone acetate to modified-release hydrocortisone in a group of patients with adrenal insufficiency
por: Frigerio, Sofia, et al.
Publicado: (2023)

OR30-06 Hospitalisation, Intensive Care And Death Due To COVID-19 In Swedish Patients With Adrenal Insufficiency
por: Bergthorsdottir, Ragnhildur, et al.
Publicado: (2023)

Patients with adrenal insufficiency have cardiovascular features associated with hypovolemia
por: Esposito, Daniela, et al.
Publicado: (2020)

Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study
por: Nilsson, Anna G, et al.
Publicado: (2017)

Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency
por: Guarnotta, V, et al.
Publicado: (2019)

Editorial: Primary Adrenal Insufficiency - Quality of Life and Long-Term Outcome With Current Treatment Strategies
por: Esposito, Daniela, et al.
Publicado: (2022)

Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate Therapy
por: Colombo, Carla, et al.
Publicado: (2018)

MON-330 Cancer Incidence in 1,296 Patients with Acromegaly Is Not Increased: A Nationwide Population-Based Study
por: Esposito, Daniela, et al.
Publicado: (2020)

Early Metabolic Benefits of Switching Hydrocortisone to Modified Release Hydrocortisone in Adult Adrenal Insufficiency
por: Bannon, Christopher A. M., et al.
Publicado: (2021)

Medical Uses of Cortisone, Including Hydrocortisone and Corticotropin
por: Bondy, Philip K.
Publicado: (1955)

Crystal structure of hydrocortisone 17-butyrate
por: Zhu, Yu, et al.
Publicado: (2014)

Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency
por: Nilsson, A G, et al.
Publicado: (2014)

Adrenal venous sampling in patients with ACTH-independent hypercortisolism
por: Papakokkinou, Eleni, et al.
Publicado: (2019)

Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management
por: Esposito, Daniela, et al.
Publicado: (2019)

Poor Response to Substitution Therapy with Cortisone Acetate in Patients with Congenital Adrenal Hyperplasia
por: Inada, Hiroshi, et al.
Publicado: (2004)

Confounding effects of liquorice, hydrocortisone, and blood contamination on salivary cortisol but not cortisone
por: Imamovic, Marcus, et al.
Publicado: (2022)

Δ1-Dehydrogenation and C20 Reduction of Cortisone and Hydrocortisone Catalyzed by Rhodococcus Strains
por: Costa, Stefania, et al.
Publicado: (2020)

Improved Urinary Cortisol Metabolome in Addison Disease: A Prospective Trial of Dual-Release Hydrocortisone
por: Espiard, Stéphanie, et al.
Publicado: (2020)

Salivary Cortisol and Cortisone After Low-Dose Corticotropin Stimulation in the Diagnosis of Adrenal Insufficiency
por: Mak, Ingrid Yin Fung, et al.
Publicado: (2017)

Residual endogenous corticosteroid production in patients with adrenal insufficiency
por: Vulto, Annet, et al.
Publicado: (2019)

Health Care Burden in Patients With Adrenal Insufficiency
por: Gunnarsson, Candace, et al.
Publicado: (2017)

THERAPY OF ENDOCRINE DISEASE: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe
por: Grossman, Ashley, et al.
Publicado: (2013)

Dual-release hydrocortisone improves hepatic steatosis in patients with secondary adrenal insufficiency: a real-life study
por: Guarnotta, Valentina, et al.
Publicado: (2019)

Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency
por: Gasco, V., et al.
Publicado: (2022)

Bone safety of dual-release hydrocortisone in patients with autoimmune primary adrenal insufficiency
por: Bioletto, Fabio, et al.
Publicado: (2023)

Tissue Glucocorticoid Metabolism in Adrenal Insufficiency: A Prospective Study of Dual-release Hydrocortisone Therapy
por: Dineen, Rosemary A, et al.
Publicado: (2023)

The diagnostic value of salivary cortisol and salivary cortisone in patients with suspected hypercortisolism
por: Berndt, Vendela, et al.
Publicado: (2022)

Exenatide Alters Absorption of Hydrocortisone in a Diabetic Patient With Panhypopituitarism: Iatrogenic Adrenal Insufficiency
por: Fujita, Yukari, et al.
Publicado: (2013)

Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency
por: Quinkler, Marcus, et al.
Publicado: (2016)

THE INFLUENCE OF CORTISONE ON EXPERIMENTAL VIRAL INFECTION : VI. INHIBITION BY HYDROCORTISONE OF INTERFERON SYNTHESIS IN THE CHICK EMBRYO
por: Smart, K. Marilyn, et al.
Publicado: (1966)

The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy
por: Dineen, Rosemary, et al.
Publicado: (2020)

Measurements of hydrocortisone and cortisone for longitudinal profiling of equine plasma by liquid chromatography–tandem mass spectrometry
por: Tou, Kathy, et al.
Publicado: (2022)

OR30-01 Waking Salivary 11-hydroxyandrostenedione And Cortisone As A Novel Non-invasive Test For Adrenal Insufficiency
por: Lawrence, Neil Richard, et al.
Publicado: (2023)

Hydrocortisone malabsorption due to polyethylene glycols (Macrogol 3350) in a girl with congenital adrenal insufficiency
por: Stagi, Stefano, et al.
Publicado: (2014)

Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study
por: Johannsson, Gudmundur, et al.
Publicado: (2016)

Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone—Results from a randomized controlled trial
por: Werumeus Buning, Jorien, et al.
Publicado: (2017)

Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.
por: Ponder, B. A., et al.
Publicado: (1984)

In Vitro Evaluation of Cocoa Pod Husk Pectin as a Carrier for Chronodelivery of Hydrocortisone Intended for Adrenal Insufficiency
por: Adi-Dako, Ofosua, et al.
Publicado: (2017)

SAT-391 Perioperative Glucocorticoid Therapy for Patients with Adrenal Insufficiency: Dosing Based on Hydrocortisone Pharmacokinetic Data
por: Rahhal, Marie-Noel, et al.
Publicado: (2019)

Editorial: Adrenal insufficiency: Diagnostic approaches, treatments and outcomes
por: Pazderska, A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ql91agj9j78dmf58deoeuck71m